Glenmede Trust’s ICU Medical ICUI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.1M | Sell |
78,366
-9,928
| -11% | -$1.43M | 0.05% | 329 |
|
|
2025
Q4 | $12.6M | Buy |
+88,294
| New | +$11.8M | 0.06% | 281 |
|
|
2025
Q1 | $1.21M | Sell |
8,704
-25
| -0.3% | -$3.88K | 0.01% | 650 |
|
|
2024
Q4 | $1.35M | Buy |
8,729
+328
| +4% | +$55.5K | 0.01% | 632 |
|
|
2024
Q3 | $1.53M | Sell |
8,401
-393
| -4% | -$58.2K | 0.01% | 624 |
|
|
2024
Q2 | $1.04M | Sell |
8,794
-103
| -1% | -$10.8K | 0.01% | 680 |
|
|
2024
Q1 | $955K | Buy |
8,897
+123
| +1% | +$12.2K | ﹤0.01% | 722 |
|
|
2023
Q4 | $875K | Buy |
8,774
+212
| +2% | +$20.7K | ﹤0.01% | 731 |
|
|
2023
Q3 | $1.02M | Buy |
8,562
+499
| +6% | +$74.5K | 0.01% | 651 |
|
|
2023
Q2 | $1.33M | Hold |
8,063
| – | – | 0.01% | 590 |
|
|
2023
Q1 | $1.33M | Buy |
8,063
+78
| +1% | +$13.4K | 0.01% | 591 |
|
|
2022
Q4 | $1.26M | Sell |
7,985
-58
| -0.7% | -$8.83K | 0.01% | 606 |
|
|
2022
Q3 | $1.21M | Sell |
8,043
-64,119
| -89% | -$10.7M | 0.01% | 606 |
|
|
2022
Q2 | $11.9M | Sell |
72,162
-6,956
| -9% | -$1.34M | 0.07% | 316 |
|
|
2022
Q1 | $17.6M | Sell |
79,118
-824
| -1% | -$185K | 0.09% | 278 |
|
|
2021
Q4 | $19M | Sell |
79,942
-796
| -1% | -$186K | 0.09% | 258 |
|
|
2021
Q3 | $18.8M | Sell |
80,738
-1,004
| -1% | -$211K | 0.1% | 241 |
|
|
2021
Q2 | $16.8M | Sell |
81,742
-145
| -0.2% | -$29.8K | 0.09% | 261 |
|
|
2021
Q1 | $16.8M | Buy |
81,887
+7,296
| +10% | +$1.54M | 0.09% | 250 |
|
|
2020
Q4 | $16M | Sell |
74,591
-5,475
| -7% | -$1.06M | 0.09% | 256 |
|
|
2020
Q3 | $14.6M | Sell |
80,066
-11,247
| -12% | -$2.12M | 0.09% | 250 |
|
|
2020
Q2 | $16.8M | Sell |
91,313
-18,376
| -17% | -$3.65M | 0.1% | 240 |
|
|
2020
Q1 | $20.5M | Hold |
109,689
| – | – | 0.09% | 276 |
|
|
2019
Q4 | $20.5M | Sell |
109,689
-13,402
| -11% | -$2.31M | 0.09% | 276 |
|
|
2019
Q3 | $19.6K | Sell |
123,091
-9,309
| -7% | -$1.85M | 0.09% | 273 |
|
|
2019
Q2 | $33.4K | Sell |
132,400
-35,358
| -21% | -$8.19M | 0.15% | 200 |
|
|
2019
Q1 | $40.1K | Buy |
167,758
+23,656
| +16% | +$5.67M | 0.18% | 168 |
|
|
2018
Q4 | $33.1K | Sell |
144,102
-26,065
| -15% | -$6.43M | 0.16% | 183 |
|
|
2018
Q3 | $48.1M | Buy |
170,167
+13,760
| +9% | +$4.03M | 0.19% | 162 |
|
|
2018
Q2 | $45.9M | Sell |
156,407
-13,271
| -8% | -$3.63M | 0.2% | 160 |
|
|
2018
Q1 | $36.6M | Hold |
169,678
| – | – | 0.15% | 202 |
|
|
2017
Q4 | $36.6M | Sell |
169,678
-92,703
| -35% | -$18.8M | 0.15% | 202 |
|
|
2017
Q3 | $48.8M | Sell |
262,381
-89,814
| -26% | -$15.7M | 0.21% | 137 |
|
|
2017
Q2 | $53.8M | Hold |
352,195
| – | – | 0.26% | 104 |
|
|
2017
Q1 | $53.8M | Buy |
352,195
+121,767
| +53% | +$17.8M | 0.26% | 104 |
|
|
2016
Q4 | $34M | Sell |
230,428
-42,999
| -16% | -$6.22M | 0.18% | 191 |
|
|
2016
Q3 | $34.6M | Buy |
273,427
+263,917
| +2,775% | +$31.8M | 0.19% | 162 |
|
|
2016
Q2 | $1.07M | Buy |
9,510
+7,287
| +328% | +$756K | 0.01% | 733 |
|
|
2016
Q1 | $230K | Buy |
2,223
+2,101
| +1,722% | +$201K | ﹤0.01% | 1127 |
|
|
2015
Q4 | $12K | Hold |
122
| – | – | ﹤0.01% | 2017 |
|
|
2015
Q3 | $12K | Buy |
122
+27
| +28% | +$2.89K | ﹤0.01% | 2056 |
|
|
2015
Q2 | $8K | Buy |
+95
| New | +$8.88K | ﹤0.01% | 2144 |
|
|
2013
Q4 | – | Sell |
-118,575
| Closed | -$7.97M | – | 2305 |
|
|
2013
Q3 | $7.97M | Buy |
118,575
+16,812
| +17% | +$1.2M | 0.09% | 267 |
|
|
2013
Q2 | $7.33M | Buy |
+101,763
| New | +$6.73M | 0.09% | 244 |
|
Other funds holding ICUI
VPM
VCM
RRAM
Glenmede Trust's ICUI Position: Q1 2026 in Review
Glenmede Trust reduced its ICU Medical (ICUI) stake by 11% in Q1 2026, selling an estimated $1.43M and leaving 78,366 shares worth $10.1M. The position accounts for 0.05% of the portfolio, ranked #329.
Glenmede Trust first reported a position in ICUI in Q2 2013 and has held it in 44 quarters since. The position peaked at $53.8M in Q2 2017. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.
- Glenmede Trust held 78,366 shares of ICU Medical worth $10.1M as of Q1 2026.
- Glenmede Trust sold 9,928 ICU Medical shares in Q1 2026, an estimated $1.43M.
- ICU Medical made up 0.05% of Glenmede Trust's portfolio in Q1 2026, its #329 holding.
- Glenmede Trust first reported a position in ICU Medical in Q2 2013 and has held it in 44 quarters since.
- Glenmede Trust's ICU Medical position peaked at $53.8M in Q2 2017.
- 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.
Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.